UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|||||
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
||
of incorporation) |
|
File Number) |
|
Identification No.) |
||
|
|
|
||||
|
|
|
||||
(Address of principal executive offices) |
||||||
Registrant's telephone number, including area code: +
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
|
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
In connection with the planned separation of Alkermes plc’s (the “Company”) oncology business into Mural Oncology plc (“Mural”), a new, independent, publicly traded company, the Company’s board of directors has set November 6, 2023 as the record date to determine shareholders of the Company eligible to receive the distribution of Mural ordinary shares. No action is required by the Company’s shareholders in order to receive ordinary shares of Mural in the distribution. The record date is subject to completion of review by the U.S. Securities and Exchange Commission (the “SEC”) of Mural’s Registration Statement on Form 10 (the “Form 10”), the SEC declaring the Form 10 effective, and completion of the listing process for Mural to trade on the Nasdaq Global Market.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ALKERMES PLC |
||
|
|
||
Date: October 27, 2023 |
By: |
|
/s/ David J. Gaffin |
|
|
|
David J. Gaffin |
|
|
|
Secretary |
3
Document and Entity Information |
Oct. 27, 2023 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Oct. 27, 2023 |
| Entity Registrant Name | Alkermes plc. |
| Entity Central Index Key | 0001520262 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-35299 |
| Entity Incorporation, State or Country Code | L2 |
| Entity Tax Identification Number | 98-1007018 |
| Entity Address, Address Line One | Connaught House |
| Entity Address, Address Line Two | 1 Burlington Road |
| Entity Address, City or Town | Dublin 4 |
| Entity Address, Country | IE |
| Entity Address, Postal Zip Code | D04 C5Y6 |
| City Area Code | 353 |
| Local Phone Number | 1-772-8000 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Ordinary shares, $0.01 par value |
| Trading Symbol | ALKS |
| Security Exchange Name | NASDAQ |